Why GRAL? GRAIL, Inc. Analysis, Price & AI Insights | Whystock
GRAL
$57.49+3.09 (+5.69%)
Market OpenUpdated 10:16 AM EDT
GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally.